AU3336499A - Use of a fluoride ion vector for preparing a medicine for preventing or treatingdiseases associated with helicobacter pylori - Google Patents

Use of a fluoride ion vector for preparing a medicine for preventing or treatingdiseases associated with helicobacter pylori

Info

Publication number
AU3336499A
AU3336499A AU33364/99A AU3336499A AU3336499A AU 3336499 A AU3336499 A AU 3336499A AU 33364/99 A AU33364/99 A AU 33364/99A AU 3336499 A AU3336499 A AU 3336499A AU 3336499 A AU3336499 A AU 3336499A
Authority
AU
Australia
Prior art keywords
medicine
preparing
helicobacter pylori
fluoride ion
treatingdiseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33364/99A
Inventor
Claudine Finidori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU3336499A publication Critical patent/AU3336499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

The invention concerns the use of at least one pharmaceutically acceptable fluoride ion vector for preparing a medicine for prevention or adjuvant therapy treatment of a disease associated with Helicobacter pylori.
AU33364/99A 1998-05-04 1999-04-20 Use of a fluoride ion vector for preparing a medicine for preventing or treatingdiseases associated with helicobacter pylori Abandoned AU3336499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9805597A FR2778104B1 (en) 1998-05-04 1998-05-04 USE OF A FLUORIDE ION VECTOR FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION OR TREATMENT OF DISEASES ASSOCIATED WITH HELICOBACTER PYLORI
FR9805597 1998-05-04
PCT/FR1999/000920 WO1999056756A1 (en) 1998-05-04 1999-04-20 Use of a fluoride ion vector for preparing a medicine for preventing or treating diseases associated with helicobacter pylori

Publications (1)

Publication Number Publication Date
AU3336499A true AU3336499A (en) 1999-11-23

Family

ID=9525983

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33364/99A Abandoned AU3336499A (en) 1998-05-04 1999-04-20 Use of a fluoride ion vector for preparing a medicine for preventing or treatingdiseases associated with helicobacter pylori

Country Status (6)

Country Link
EP (1) EP1075268B1 (en)
AT (1) ATE300307T1 (en)
AU (1) AU3336499A (en)
DE (1) DE69926353T2 (en)
FR (1) FR2778104B1 (en)
WO (1) WO1999056756A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111888323A (en) * 2020-08-25 2020-11-06 王祥 Oral bacteriostatic cream for children and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996024341A1 (en) * 1995-02-07 1996-08-15 Narayan Krishnarao Athanikar Concomitant treatment with bismuth and antibacterials

Also Published As

Publication number Publication date
FR2778104B1 (en) 2002-08-30
DE69926353T2 (en) 2006-06-01
EP1075268A1 (en) 2001-02-14
FR2778104A1 (en) 1999-11-05
EP1075268B1 (en) 2005-07-27
ATE300307T1 (en) 2005-08-15
WO1999056756A1 (en) 1999-11-11
DE69926353D1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
EP1029540A3 (en) Use of droloxifene for the treatment of cardiovascular diseases
CA2111002A1 (en) Non-Chlorofluorocarbon Aerosol Formulations
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
NO308854B1 (en) Therapeutic Compounds, Pharmaceutically Acceptable Salts and Formulations Containing the Compounds, and Uses thereof
PL309693A1 (en) Combined osteoporosis inhibiting treatment
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
AU5873498A (en) Mutant (msbb) or (htrb) genes
WO1999004772A3 (en) Use of levobupivacaine
CA2264063A1 (en) Cryptophycin compounds
WO1992018111A3 (en) Pharmaceutical composition for the treatment of gastritis
AU6682298A (en) Use of r-nsaid's for the prevention of alzheimer's disease
WO2000051582A3 (en) Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
AU7105498A (en) Combination therapy for the prevention and treatment of osteoporosis
AU3336499A (en) Use of a fluoride ion vector for preparing a medicine for preventing or treatingdiseases associated with helicobacter pylori
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
CA2330424A1 (en) Improved method for eradication of helicobacter pylori
AU7982098A (en) Use of beta2-adrenoceptor agonists for the manufacture of a medicament for the treatment of scoliosis
EP0869786A4 (en) Pharmaceutical compounds
BG106151A (en) Pharmaceutical complex
WO2002083083A3 (en) Pharmaceutically active compounds and methods of use
WO1999064065A3 (en) Tumour therapy and imaging
MX9710093A (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases.
GB9910117D0 (en) Shut-off valve for medical endoscopes
MX9802809A (en) Urease for the treatment of helicobacter pylori infections.
WO2000010544A3 (en) A method for preventing the onset of asthma

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase